Litigation/Liability Trends
Pfizer’s Gets Celebrex Patent Extended, Sues Generic Makers
U.S. regulators granted Pfizer Inc. a reissued patent on its multibillion-dollar Celebrex pain drug that extends its marketing exclusivity until early December 2015, the company said on Tuesday. That ...BP Faces August 2014 Trial On Shareholders’ Gulf Spill Claims
A U.S. civil trial has been set for Aug. 25, 2014, regarding accusations that BP Plc committed fraud by misleading shareholders before and after the 2010 Gulf of Mexico oil spill about its ability to ...Banks Urge U.S. Judge To Throw Out LIBOR Lawsuits
Banks facing a barrage of lawsuits from customers accusing them of interest-rate rigging argued on Tuesday that the cases should be dismissed, saying there is no evidence of antitrust or other ...Monster Beverage Says Energy Drinks Did Not Kill Teen
Monster Beverage Corp., defending its Monster Energy drinks from mounting criticism about potential health risks, said on Monday its medical investigators found no evidence that the drinks caused the ...Facebook Hit With IPO-Related Derivative Lawsuit
A Facebook Inc. shareholder filed a lawsuit over the largest social networking company's botched initial public offering and is seeking to hold Chief Executive Mark Zuckerberg, directors and officers ...